Free Trial

Asset Management One Co. Ltd. Decreases Stake in Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Asset Management One Co. Ltd. trimmed its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 19.6% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,761 shares of the business services provider's stock after selling 11,624 shares during the quarter. Asset Management One Co. Ltd. owned approximately 0.09% of Exponent worth $3,898,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Raymond James Financial Inc. bought a new stake in shares of Exponent during the fourth quarter valued at approximately $55,131,000. Norges Bank purchased a new position in Exponent during the fourth quarter valued at $52,381,000. Resona Asset Management Co. Ltd. bought a new stake in shares of Exponent during the 4th quarter valued at $38,538,000. BLI Banque de Luxembourg Investments purchased a new stake in shares of Exponent in the 4th quarter worth about $12,564,000. Finally, Barclays PLC grew its position in shares of Exponent by 88.5% in the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock worth $16,209,000 after buying an additional 85,395 shares during the period. 92.37% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, VP John Pye sold 2,000 shares of the stock in a transaction on Friday, May 23rd. The stock was sold at an average price of $76.32, for a total value of $152,640.00. Following the sale, the vice president directly owned 29,204 shares of the company's stock, valued at approximately $2,228,849.28. This represents a 6.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Bradley A. James sold 2,694 shares of the company's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $79.52, for a total transaction of $214,226.88. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,267 shares of company stock valued at $489,120. 1.60% of the stock is currently owned by corporate insiders.

Exponent Stock Performance

Shares of Exponent stock traded down $0.29 during trading on Thursday, hitting $77.32. The company's stock had a trading volume of 186,368 shares, compared to its average volume of 258,222. Exponent, Inc. has a 52 week low of $72.43 and a 52 week high of $115.75. The company has a market capitalization of $3.92 billion, a PE ratio of 37.71 and a beta of 0.90. The company has a fifty day simple moving average of $76.88 and a two-hundred day simple moving average of $82.88.

Exponent (NASDAQ:EXPO - Get Free Report) last announced its earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The business had revenue of $137.44 million during the quarter, compared to the consensus estimate of $134.63 million. During the same quarter last year, the firm earned $0.59 earnings per share. The business's revenue for the quarter was up .2% on a year-over-year basis. As a group, analysts predict that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date of this dividend was Friday, June 6th. Exponent's payout ratio is 58.54%.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Articles

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines